Kazuhiko Watabe

Kazuhiko Watabe

Auto-generated profile, based on publicly available information

Kazuhiko Watabe

ALS/Neuropathy Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

44Years (1983-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2008 in Journal of Biomedical Materials Research Part A
Verified
Journal Article
Closed access
PDF file
WWWei Wang
Wei Wang
SISoichiro Itoh
Soichiro Itoh
KKKatsumi Konno
Katsumi Konno
TKTakeshi Kikkawa
Takeshi Kikkawa
SIShizuko Ichinose
Shizuko Ichinose
KWKazuhiko Watabe
Kazuhiko Watabe

1 June 1995 in Journal of Neuroscience Research
Verified
Journal Article
Closed access
PDF file
KWK. Watabe
K. Watabe
TFT. Fukuda
T. Fukuda
JTJ. Tanaka
J. Tanaka
HHH. Honda
H. Honda
KTK. Toyohara
K. Toyohara
OSO. Sakai
O. Sakai

21 October 2008 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
MHManabu Hashimoto
Manabu Hashimoto
KIKunihiro Ishii
Kunihiro Ishii
YNYasuko Nakamura
Yasuko Nakamura
KWKazuhiko Watabe
Kazuhiko Watabe
SKShinichi Kohsaka
Shinichi Kohsaka
CAChihiro Akazawa
Chihiro Akazawa
The physiological roles of sonic hedgehog (Shh) have been intensively characterized in development of various organs. However, their functions in adult tissues have not been fully elucidated. We investigated the expression and the potential function of Shh in crush‐injured adult rat sciatic nerves. The Shh expression was up‐regulated in Schwann cells adjacent to the injured site. The time‐course analyses of various neurotrophic factors revealed the up‐regulation of Shh mRNA followed by that of brain‐derived neurotrophic factor (BDNF) mRNA. The continuous administration of cyclopamine, a hedgehog signal inhibitor, to the injured site suppressed the increase of BDNF expression and deteriorated the survival of motor neurons in lumbar spinal cord. Treatment of exogenous Shh in cultured Schwann cells enhanced the BDNF expression. The BDNF promoter activity (exon I and II) was increased in IMS32 cells co‐transfected with Shh and its receptor Smoothened. These findings imply that the up‐regulated expression of Shh in Schwann cells may play an important role in injured motor neurons through the induction of BDNF.

24 January 2003 in Journal of Neuroscience Research
Verified
Journal Article
Closed access
PDF file
TSTsuyoshi Sakamoto
Tsuyoshi Sakamoto
YKYoko Kawazoe
Yoko Kawazoe
JSJin‐Song Shen
Jin‐Song Shen
YTYasuo Takeda
Yasuo Takeda
YAYoshihiro Arakawa
Yoshihiro Arakawa
KWKazuhiko Watabe
Kazuhiko Watabe

31 December 2009 in The American Journal of Pathology
Verified
Journal Article
Closed access
HWHaruka Wada
Haruka Wada
TYTakuwa Yasuda
Takuwa Yasuda
IMIkuo Miura
Ikuo Miura
KWKazuhiko Watabe
Kazuhiko Watabe
CSChika Sawa
Chika Sawa
KSKen-Ichiro Seino
Ken-Ichiro Seino

1 July 2001 in Gene Therapy
Verified
Journal Article
Open access
PDF file
JSJs Shen
Js Shen
KWK Watabe
K Watabe
TOT Ohashi
T Ohashi
YEY Eto
Y Eto
Twitcher mouse is a murine model of human globoid cell leukodystrophy (Krabbe disease), which is characterized by a genetic deficiency in galactocerebrosidase (GALC) activity. The nervous system is affected early and severely by demyelination in the white matter. So far, there is no effective treatment for Krabbe disease except bone marrow transplantation (BMT). However, BMT has inherent limitations such as unavailability of donors and graft-versus-host disease. In this study, we injected recombinant adenovirus encoding GALC into the lateral ventricle of twitcher mice at postnatal day 0 (PND 0) and the therapeutic effects were evaluated. Our results showed slight, but significant improvements in motor functions, body weight and twitching and a prolonged life span. In brain, GALC activity was increased to 15% that of normal littermates and psychosine concentration was decreased to 55% that of untreated twitcher mice at PND 15. The number of PAS-positive globoid cells in brain stem was also reduced significantly at PND 35. In contrast, when adenoviruses were injected to the twitcher mice at PND 15, almost no improvements were observed. These results demonstrate that the timing of treatment may be of great importance in Krabbe disease.